Kumar, A. S., & Samuel, V. (2025). Cost-Effectiveness of Co-Amoxiclav Versus Clindamycinin the Treatment of Uncomplicated Soft Tissue Infections in a Tertiary Care Hospital. Journal of Health and Technology, 1(1), 15–22. https://doi.org/10.65129/clinical.v1i1.25